January 16, 2025 - 19:43

The latest retail sales report for December indicates a slower-than-anticipated growth, raising concerns among investors about the overall health of consumer spending. As the Federal Reserve prepares to maintain elevated interest rates for an extended period, these figures are particularly significant. The report shows that while December sales did increase, the growth was less robust than analysts had predicted, suggesting a potential cooling in consumer demand.
In contrast, November's sales figures have been revised upward, providing a somewhat brighter picture of the previous month. This adjustment may reflect a stronger-than-expected holiday shopping season, yet it does not fully alleviate concerns regarding the current economic climate. The mixed signals from these reports highlight the challenges faced by retailers and the broader economy as consumers navigate rising costs and shifting spending habits. Investors will be keenly observing future trends as they assess the implications for monetary policy and economic stability.
March 15, 2026 - 03:23
Audit finds strong oversight at Fort Worth Housing Finance Corp, flags minor control gapsA recent operational audit of the Fort Worth Housing Finance Corporation has concluded that the agency maintains strong overall oversight, though it identified a handful of minor internal control...
March 14, 2026 - 07:39
Nvidia GTC, Macy's earnings, FOMC meeting: What to WatchThe upcoming week presents a critical lineup of events for the financial markets, with major corporate developments and a key Federal Reserve meeting on the calendar. All eyes will be on the...
March 13, 2026 - 20:57
Richard Donoff Encourages Americans to Prioritize Long-Term Financial PreparednessIn a recent address, financial expert Richard Donoff emphasized the critical need for American families to shift their focus toward long-term financial preparedness. He advocates for a proactive...
March 13, 2026 - 04:55
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateCapricor Therapeutics has announced its financial results for the fourth quarter and full year 2025, alongside significant progress in its lead clinical program. The company`s Biologics License...